Dunwoody, GA, United States of America

Christos Markou

This inventor holds 1 USPTO granted patent. Top assignee: Emory University. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 503(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christos Markou: Innovator in Localized Drug Delivery

Introduction

Christos Markou is a notable inventor based in Dunwoody, GA (US). He has made significant contributions to the field of medical technology, particularly in the area of drug delivery systems. His innovative approach focuses on enhancing the effectiveness of localized treatments in the mammalian body.

Latest Patents

Markou holds a patent for a device and method for non-occlusive localized drug delivery. This device is designed for the local delivery of a substance into a natural tissue conduit within the body. It allows for the targeted delivery of therapeutic agents without significantly disrupting the fluid flow through the conduit. The patent outlines an indwelling endovascular support device that facilitates the local delivery of substances to specific treatment areas.

Career Highlights

Christos Markou is affiliated with Emory University, where he continues to advance his research and development efforts. His work is pivotal in improving medical treatments and patient outcomes through innovative drug delivery methods. With a focus on practical applications, Markou's inventions aim to bridge the gap between technology and healthcare.

Collaborations

Markou has collaborated with esteemed colleagues, including Stephen R. Hanson and Neal A. Scott. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.

Conclusion

Christos Markou's contributions to localized drug delivery exemplify the impact of innovation in healthcare. His patent and ongoing work at Emory University highlight the importance of targeted treatment methods in improving patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…